3-methyl-O-desmethylencainide

Known as: 3-MDMED 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1984-1991
01219841991

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1991
1991
Encainide metabolism is mediated by the polymorphically distributed cytochrome P450IID6, which displays stereoselectivity for… (More)
Is this relevant?
1989
1989
The disposition of encainide is under genetic control. In extensive metabolizers, the drug undergoes extensive first-pass… (More)
Is this relevant?
1989
1989
A high-performance liquid chromatography (HPLC) procedure used to quantitate encainide and two of its active metabolites, O… (More)
Is this relevant?
1986
1986
The antiarrhythmic agent encainide undergoes extensive first-pass hepatic metabolism after oral dosing. The active metabolites O… (More)
Is this relevant?
1986
1986
The antiarrhythmic agent encainide undergoes extensive presystemic biotransformation to form O-desmethylencainide (ODE) and 3… (More)
Is this relevant?
1984
1984
The metabolism of the new, highly effective antiarrhythmic agent, encainide, appears to be polymorphically distributed in a… (More)
Is this relevant?